Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Blocks help minimise metabolic disorder risks in herds

Blocks help minimise metabolic disorder risks in herds

It’s the calm before the calving season and a bit of planning now will help herds get through without the risk of metabolic disorders, such as milk fever, which can lead to downer cows or impact future milk production.

The disorders are prevalent just before or after calving, triggered by an inability to mobilise enough calcium. Subclinical cases of milk fever can be hard to pick up, with industry data indicating that for every downer cow it is likely that between 10 and 15 others in the herd will have early stage milk fever symptoms.

“It’s estimated that the cost of a clinical case of milk fever can reach up to $1,500 per cow* – including lost milk production, reduced fertility, and increased likelihood of culling due to other diseases such as mastitis. Not only is the risk a costly one, it’s also unnecessary,” says SealesWinslow Product Development Manager, Jackie Aveling.

Jackie explains there is a clear link between nutrients and vitamins, and reproduction and lactation in dairy herds.

“Using supplements pre and post calving is a good preventative strategy for metabolic diseases and also sets up cows well for lactation post calving. What’s important is ensuring supplements are readily available well before the calving really picks up from July.”

Dehydrated molasses blocks, such as Crystalyx Dry Cow can be used as a sole source supplement, and need to be available to stock for 60 days prior to calving and then throughout the colostrum period. The dehydrated molasses helps to ensure cows get the right intake, and the minerals and vitamins help to improve the general immunity of the cow.

Other options include SealesWinslow’s Cattle High Magnesium Block or the Cattle Winter Crop Block. Both are suitable for farmers who want cost-effective delivery of pre-calving magnesium supplementation as part of a programmed approach, and will help ensure stock receive the minerals and trace elements they need.

Farm trials for Crystalyx, conducted over two consecutive years, have shown dehydrated blocks are more effective than mineral supplementation dusting or dosing. The repeated trial work done by Dr Mark Oliver, a researcher contracted to Auckland UniServices Limited by the University of Auckland, saw a control herd supplemented with magnesium and trace elements following current best practice guidelines, and the other Crystalyx Dry Cow. In the first year the control cows recorded a significantly higher incidence of retained placentas (11% compared to 2.6%), while mastitis incidence also tended to be higher (9.0% versus 3.9%). A second trial achieved similar outcomes with lower rates of mastitis and retained placentas in the herd given access to the dehydrated block.

Mrs Aveling says farmers participating in the trials also commented that cows on Crystalyx were calmer, quiet and settled well into milking.


ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

$7.5 Billion Surplus: Government Accounts "Show Strong Economy"

“The surplus and low levels of debt show the economy is in good shape. This allows the Government to spend more on infrastructure and make record investments in health and education,” Grant Robertson says. More>>

ALSO:

New OIO Application Trumps Judicial Review: OceanaGold Cleared To Buy Land For Waihi Tailings Expansion

In a surprise turnaround, the government has given OceanaGold a greenlight to buy land to expand its Waihi mine after the application was previously turned down by Land Information Minister Eugenie Sage. More>>

ALSO:

Christchurch Rebuild: Fletcher Sued For $7.5m Over Justice Precinct

Fletcher Building is being sued for $7.5 million by utilities contractor Electrix, one of the subcontractors on the Christchurch Justice and Emergency Services Precinct. More>>

Three New Drugs: PHARMAC Signs Bundle Deal For More Cancer Medicines

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More>>

ALSO:

"Levels Playing Field": Government Responds To Electricity Price Review

The changes announced today include: • Supporting new and independent retailers by requiring the big power companies to sell into the wholesale market at affordable rates. • Extending discount rates to all customers • A pilot scheme to help customers who have not switched power providers before to shop around for better deals... More>>

ALSO: